BioSpace News Archive

Amgen announced that its Board of Directors declared a $1.94 per share dividend for the second quarter of 2022.

Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced that it will report financial results for the fourth quarter and full year 2021 after the market close on Wednesday, March 23, 2022.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:

First Wave BioPharma, Inc. announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 6,498,195 shares of its common stock and five-year warrants to purchase up to an aggregate of 6,498,195 shares of common stock at an exercise price of $1.26 per share, at an effective purchase price of $1.385 per share and accompanying warrant.

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 12 newly-hired employees options to purchase an aggregate of 97,000 shares of Akebia’s common stock on February 28, 2022, as inducements material to each such employee’s entering into employment with Akebia.

Acer Therapeutics Inc. (Nasdaq: ACER), today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided an update on the Company’s recent corporate developments.

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the closing of its underwritten public offering of $1.2 billion aggregate principal amount of the following notes, each issued at par.

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a GI/Microbiome panel discussion at the Cowen 42nd Annual Health Care Conference.

Celcuity Inc. today announced its participation in the virtual Cowen 42nd Annual Health Care Conference to be held March 7-9, 2022.

Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, announced that management will participate in fireside chats at two upcoming virtual conferences.